EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pioglitazone Ameliorates Mitochondrial Oxidative Stress and Inflammation via AMPK ‐Dependent Inhibition of Mitochondrial Fission in Leigh Syndrome

Jie Luo, Ling Chen, Xiaoxian Zhang, Qiang Su, Xiaoya Zhou, Qizhou Lian iD

Cell Proliferation · 2026

DOI: 10.1111/cpr.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2026. Verfasst von Jie Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cord Blood Bank Centre, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Pioglitazone, Oxidative Stress, Mitochondrial Dynamics, Mitochondria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Shenzhen Science and Technology Innovation Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss of function mutations of NDUFS4 resulted in Leigh syndrome, which is a progressive neurodegenerative disease and characterized by mitochondrial oxidative stress, inflammation and aberrant mitochondrial dynamics. However, there is currently no effective treatment. Here, we demonstrate that pioglitazone significantly mitigates mitochondrial reactive oxygen species (ROS) generation, lowers cyclooxygenase‐2 (COX‐2) mRNA levels, and rescues aberrant mitochondrial dynamics in vitro (increasing Opa‐1 expression while decreasing Drp‐1 expression). Furthermore, similar effects were observed with the selective Drp‐1 inhibitor mdivi‐1, suggesting that inhibiting mitochondrial fission mediates the therapeutic effects of pioglitazone. Pioglitazone administration activated AMPK phosphorylation, but these effects, along with pioglitazone's ability to reverse oxidative stress, inflammation, and mitochondrial fission, were abolished by the AMPK inhibitor compound C. In vivo, pioglitazone alleviated motor dysfunction, prolonged lifespan, and promoted weight gain in Ndufs4 KO mice. This was accompanied by enhanced mitochondrial fusion and increased levels of mitochondrial complex subunits. Consistently, pioglitazone attenuated neuroinflammation and oxidative stress in vivo. Collectively, our findings indicate that pioglitazone alleviates mitochondrial oxidative stress and inflammation through an AMPK‐dependent inhibition of Drp‐1‐mediated mitochondrial fission. Therefore, suppression of mitochondrial fission may represent a novel therapeutic strategy for Leigh syndrome (LS).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PioglitazoneOxidative StressMitochondrial DynamicsMitochondriaLeigh DiseaseAMP-Activated Protein KinasesInflammationAnimalsMiceMice, KnockoutReactive Oxygen SpeciesMice, Inbred C57BLElectron Transport Complex ICyclooxygenase 2MaleHumans

Substanzen

PioglitazoneAMP-Activated Protein KinasesReactive Oxygen SpeciesElectron Transport Complex INdufs4 protein, mouseCyclooxygenase 2

Autor:innen und Institutionen

  • Cord Blood Bank Centre, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Department of Endocrinology, Shenzhen Second People's Hospital, Shenzhen Clinical Research Center for Metabolic Diseases, Shenzhen Center for Diabetes Control and Prevention, the First Affiliated Hospital of Shenzhen Un…
  • CAS Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institutes of Advanced Technology, Faculty of Synthetic Biology, Chinese Academy of Sciences, Shenzhen University of Advanced Technology, Shenzhen, China.
  • Center for Translational Stem Cell Biology, Hong Kong, China.
  • HKUMed Laboratory of Cellular Therapeutics, University of Hong Kong, Hong Kong, China.
  • Department of Surgery, The University of Hong Kong Shenzhen Hospital, Shenzhen, China.

ORCID-Profile: Qizhou Lian

Förderung

  • National Key Research and Development Program of China
  • Shenzhen Science and Technology Innovation Program
  • National Natural Science Foundation of China
  • Start-up Grant for Stem Cell Regenerative Medicine

Zitieren

APA

Luo, J., Chen, L., Zhang, X., Su, Q., Zhou, X., & Lian, Q. (2026). Pioglitazone Ameliorates Mitochondrial Oxidative Stress and Inflammation via AMPK ‐Dependent Inhibition of Mitochondrial Fission in Leigh Syndrome. Cell Proliferation. https://doi.org/10.1111/cpr.70109

Vancouver

Luo J, Chen L, Zhang X, Su Q, Zhou X, Lian Q. Pioglitazone Ameliorates Mitochondrial Oxidative Stress and Inflammation via AMPK ‐Dependent Inhibition of Mitochondrial Fission in Leigh Syndrome. Cell Proliferation. 2026. doi:10.1111/cpr.70109

BibTeX
@article{Luo2026,
  author = {Luo, Jie and Chen, Ling and Zhang, Xiaoxian and Su, Qiang and Zhou, Xiaoya and Lian, Qizhou},
  title = {Pioglitazone Ameliorates Mitochondrial Oxidative Stress and Inflammation via AMPK ‐Dependent Inhibition of Mitochondrial Fission in Leigh Syndrome},
  journal = {Cell Proliferation},
  year = {2026},
  doi = {10.1111/cpr.70109}
}
Kostenlos starten →